Hirayama disease: Is surgery an option?

详细信息    查看全文

• 作者：M. Agundez^a ; I. Rouco^a ; J. Barcena^a ; B. Mateos^b ; J. Barredo^b ; J.J. Zarranz^a ; ^{JUANJOSE.ZARRANZIMIRIZALDU@osakidetza.net" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Amyotrophy ; Surgery ; Hirayama disease ; Myopathy ; Magnetic resonance imaging ; Treatment
• 刊名：Neurología (English Edition)
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：30
• 期：8
• 页码：502-509
• 全文大小：1739 K

文摘

Hirayama disease is a rare cervical myelopathy, predominantly affecting young men, and which presents with distal atrophy of the upper limbs as its first and main symptom. It must be differentiated from motor neuron diseases because its natural history is different and because HD tends to stabilise in less than 5 years.

Diagnosis is based on clinical findings and dynamic flexion MRI showing segmental spinal muscular atrophy, detachment of the posterior dura mater and venous congestion in the epidural space.

The tendency is to indicate conservative treatment and no indications for surgery have been established.

Patients

We present 4 cases meeting both clinical criteria and dynamic MRI imaging criteria for a diagnosis of Hirayama disease. Two have stabilised spontaneously over the course of many years, and MRI scans show that typical changes have disappeared. Another case also remains stable following a shorter observation time. The fourth case is a young man who developed severe myelopathy in just over a year, and therefore underwent surgery. While his follow-up time is still short, his condition remains stable.

Conclusions

Our 4 cases suggest that the condition of most patients with Hirayama stabilises naturally; patients should be evaluated for surgery on an individual basis, and surgery should probably be limited to the most severe cases that have progressed quickly.